Covid-19 RNA vaccines – a patent dispute.
On March 17, Alnylam Pharmaceuticals has filed infringement suits against Pfizer and Moderna. The concept of vaccination dates from the French Louis Pasteur (nineteenth century), where inactivated virus are
Get to know our IP specialists: 4 questions to our Patent Engineer Alexandre Sylvestre
Alex, could you explain us a bit why you have chosen for the new venture at CALYSTA ? I joined Calysta because I was intrigued how young, dynamic and diverse
Get to know our IP specialists: 4 questions to our Senior Patent Attorney Daisy Bayot
Daisy, could you tell us a bit more about your education, background and experience? My technical background is chemistry. I studied at the UCLouvain where I obtained a bachelor’s
The challenges IP is facing from 3D printing
Additive manufacturing has the potential to dramatically facilitate manufacturing processes and facilitate the copying of innovative products. The following article analyses the different challenges caused by 3D printing for the